Evidence map›Paper›PMID 35664723›Full record

ArticleIranian journal of microbiology2022

Analysis of carbapenemases genes of carbapenem-resistant

Leyla Pourgholi, Hadi Farhadinia, Maryam Hosseindokht, Shayan Ziaee, Rahim Nosrati, Marjan Nosrati, Mohammadali Boroumand

Open access · diamondAbstract read
In one paragraph

Article in Iranian journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Leyla PourgholiDepartment of Molecular Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Hadi FarhadiniaDepartment of Molecular Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Maryam HosseindokhtDepartment of Molecular Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Shayan ZiaeeDepartment of Molecular Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Rahim NosratiCellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Marjan NosratiDepartment of Infection Control, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadali BoroumandDepartment of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRGuilan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Emerging of carbapenem-resistant Materials and Methods: This study was performed on 71 CRKP strains isolated from different clinical specimens collected in Tehran Heart Center (Tehran, Iran). A Modified Hodge test (MHT) was done for the detection of carbapenemase-producing Results: We identified 8.82% (71/805) of Conclusion: The relatively high frequency of some carbapenemase genes suggests major concern about the emergence of isolates containing carbapenem resistance genes as a potential health threat.

Indexed as

blaIMPblaNDMblaOXA-48blaVIMCarbapenem-resistanceKlebsiella pneumoniae

Identifiers

PMID35664723
PMCPMC9085547
OpenAlexW4213191504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.